Live Breaking News & Updates on Alzheimer Amp 39 S

Stay updated with breaking news from Alzheimer amp 39 s. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Historical medical treatment found to 'transmit' Alzheimer's

A new study shows the first known evidence of Alzheimer's in living people that appears to have been acquired as a result of previous medical treatments. ....

United Kingdom , University College , New South Wales , City Of , Steve Collins , Jonathan Schott , Florey Institute Of Neuroscience , National Hospital For Neurology , Queen Square Institute Of Neurology , Australian National Creutzfeldt Jakob Disease Registry , Foundation Trust , Mental Health , Researchers At University College London , National Prion Clinic , University College London Hospitals , Nature Medicine , University College London , Prion Clinic , National Hospital , Professor Colin Masters , Professor Steve Collins , Florey Institute , Professor Jonathan Schott , Square Institute , Alzheimer Amp 39 S , Nature Medicine ,

Exosome-based drug delivery system for Alzheimer's treatment

Researchers have developed a novel approach to deliver the bioactive compound Corynoxine-B to the brains of Alzheimer's patients using exosomes. ....

Ashok Iyaswamy , Hong Kong Baptist University , Signal Transduction , Professor Li Min , Associate Dean , Chinese Medicine , Alzheimer Amp 39 S , Hong Kong Baptist University , Drug Delivery , Ignal Transduction And Targeted Therapy , Orynoxine B ,

Two new approaches for treating Alzheimer's disease

Scientists have restored the nerve cell connections in the brain that are destroyed by Alzheimer's, while others have found a connection between the health of blood vessels and development of the disease. ....

New South Wales , Bryce Vissel , Institute Healthy Ageing Centre , Hospital Sydney , Molecular Neurodegeneration , Centenary Institute , Healthy Ageing Centre , Alzheimer Amp 39 S , Centenary Institute , Enescent Blood Vessel Cells , Blood Brain Barrier , Molecular Neurodegeneration , Erve Cell Connections ,

T cells in the brain slow progression of Alzheimer's

Scientists have found that a subset of CD8<sup>+</sup> T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer's disease. ....

Jordy Saravia , Hongbo Chi , Wei Su , Jude Children Research Hospital , Jude Children , Research Hospital , Alzheimer Amp 39 S , St Jude Childrens Research Hospital , Nature Immunology , Cd8t Cells , Immune Cells ,

Cognitive decline slowed in Alzheimer's drug trial

The phase 3 drug trial from Eli Lilly and Company indicated significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's. ....

Mark Mintun , Anne White , Daniel Skovronsky , Eli Lilly , Eric Reiman , Group Vice , Lilly Research Laboratories , Alzheimer Disease Cooperative Study , Neuroscience Research Development At Lilly , Banner Research , Centers For Medicare Medicaid Services , National Coverage Determination , Disease Rating Scale , Chief Scientific , Medical Officer , Lilly Research , Clinical Dementia Rating Sum , Disease Cooperative Study , Daily Living Inventory , Group Vice President Neuroscience Research , Executive Vice President , Medicaid Services , National Coverage , Association International Conference , Alzheimer Amp 39 S , Phase 3 ,